now on twitter! twitter.com/alicepennyland
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(SPPH.PK) announced earlier this week, its results for their Diabetes (Metformin) platform being conducted at their research lab at the University of Quebec at Montreal (UQAM).
SPPH is really trying to modernize the identification of new drug delivery applications.
This is impressive-Market capital of over $90 million.
Great call!
Just some more stuff I'm finding- float level of less than 46 million shares.
I also read that they had worked with both INSA Rouen and UQAM on those patents
Also displaying increased volume of over 4x.
Increase in price per share over 9% on just Friday
I'm definitely thinking it will too- more people are getting in on it
Rose in share price of over 130% in the last week!!
I agree, so companies like this are going to be in increasingly high demand
you're welcome! Glad it helped
By the way.. I'll probably just post it here as I find it...this board could use even more DD.
Yea, you're so right- it is going so well
This stock has so much promise
Yea especially with all the baby boomers hitting old age
hahaha same exact position for me! ...It is at current support levels though...and I've been watching this stock for a long time now...shoul rally back soon.
hahah you can say that again...I think this is definitely looking to get the momentum it needs.
Given that Diabetes is the sixth leading cause of death in the US, Spencer Pharmaceutical is well positioned to address the growth of this market with its proprietary "controlled release" technology.
For sure- I think it will be
wow...SPPH is definitely tapping a cash cow..and with a SUCCESSFUL DRUG
The global diabetes market was worth$18.6bn in 2005, which was an 11.5% increase from 2004 sales of $16.6bn.
METAFORMIN: "When compared to the existing commercial formulations our tablet showed significant advantages to the incumbent technologies," stated CEO Dr. Max Arella.
They are working on 2 patent applications?! Anyone know for what?
IMO...this is currently undervalued at 35 cents per share.
Rose in share price of over 130% in the last week.
Increase in price per share over 9% on just Friday
Displaying increased volume of over 4x.
Float level of less than 46 million shares.
Market capital of over $90 million.
Now that the technicals are set and have me confident, I'm gonna try and find some DD...
Yea, definitely not a one day wonder- Surprised more people haven't gotten on board with this
Actually, the technicals are pretty nice on this one...I think I might do a chart.
Currently undervalued at 35 cents per share!
Came up on a scanner for me on Friday...diving into some DD now, seeing what I can scoop up before I jump in.
nice...glad to see you're on board. It's really usually an influx of a positive mental attitude that mainly drives these stocks.
Spencer Pharmaceutical is developing a newly patented formulation of existing drugs from the incubation to the developmental stages or newly synthesized drugs able to cross the blood-brain barrier- their research work has been nearly a 15 yr process!!!
Yea...this company is too great to leave a bad taste in people's mouths...in my very honest opinion...I feel as though strong hands will be happily rewarded here.